ERCC5 and ovarian carcinoma: Furthermore, high expression of XPG at the RNA level in ovarian cancer has been associated with poor overall survival compared with patients with low expression [41], while XPF and XPG knockdown in osteosarcoma cell line resulted in better platinum-based treatment response [46].